Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
McKesson
Medtronic
Argus Health
McKinsey
Deloitte
Harvard Business School
Daiichi Sankyo
Accenture

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 086598

« Back to Dashboard

NDA 086598 describes NANDROLONE DECANOATE, which is a drug marketed by Abraxis Pharm, Akorn, Luitpold Pharms Inc, and Watson Labs, and is included in ten NDAs. It is available from one supplier. Additional details are available on the NANDROLONE DECANOATE profile page.

The generic ingredient in NANDROLONE DECANOATE is nandrolone decanoate. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nandrolone decanoate profile page.
Summary for 086598
Tradename:NANDROLONE DECANOATE
Applicant:Watson Labs
Ingredient:nandrolone decanoate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength100MG/ML
Approval Date:Jan 13, 1984TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Colorcon
Queensland Health
Mallinckrodt
AstraZeneca
Teva
Cerilliant
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.